John L. Workman - 20 May 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for John L. Workman by Power of Attorney
Issuer symbol
CNMD
Transactions as of
20 May 2025
Net transactions value
+$28,663
Form type
4
Filing time
21 May 2025, 16:25:37 UTC
Previous filing
23 Apr 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Workman John L Director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO /s/ Thomas Fistek for John L. Workman by Power of Attorney 21 May 2025 0001302537

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $28,663 +479 +2.3% $59.84 20,891 20 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD RSUs (Restricted Stock Units) Options Exercise $0 -479 -100% $0.000000 0 20 May 2025 Common Stock 479 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John L. Workman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.